甘精胰岛素用于超低出生体重儿新生儿高血糖管理
本文报告一例对常规治疗无效的显著高血糖的超低出生体重(ELBW)婴儿,经皮下长效甘精胰岛素治疗后反应良好。文章指出常规胰岛素与长效胰岛素药代动力学不同,但两者在ELBW婴儿中的药代动力学尚不明确,需进一步研究以安全实现每日一次给药维持血糖正常。
要点
- ELBW婴儿高血糖常与生理应激、外源性葡萄糖输注及产后皮质激素治疗有关。
- 长效甘精胰岛素曾用于早产儿暂时性新生儿糖尿病,但用于医源性新生儿高血糖的报道较少。
- 本病例中ELBW婴儿对常规治疗无效的高血糖对皮下长效甘精胰岛素反应良好。
核心结论
- 皮下长效甘精胰岛素可能对常规治疗无效的ELBW婴儿显著高血糖有效。
- 常规胰岛素与长效胰岛素药代动力学不同,但两者在ELBW婴儿中尚不明确。
- 需进一步研究长效胰岛素以安全实现每日一次给药维持血糖正常。
研究设计与样本
- 本文为个案报告,对象为一名超低出生体重(ELBW)婴儿。
主要发现
- 该ELBW婴儿存在显著高血糖,对常规治疗无效,但对皮下长效甘精胰岛素反应良好。
- 常规胰岛素皮下注射后分解为有生物活性的单体,长效胰岛素形成微沉淀并在中性生理pH下逐渐释放。
- 常规胰岛素和长效胰岛素在ELBW婴儿中的药代动力学尚不明确。
临床怎么用
- 对常规治疗无效的ELBW婴儿显著高血糖,可考虑皮下长效甘精胰岛素治疗。
- 使用长效甘精胰岛素时需注意其在ELBW婴儿中的药代动力学尚不明确,应进一步研究以安全实现每日一次给药维持血糖正常。
局限性
- 本文为个案报告,证据级别有限。
- 常规胰岛素和长效胰岛素在ELBW婴儿中的药代动力学尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neonatal hyperglycemia is common in extremely low birth weight (ELBW) infants because of physiologic stress, exogenous glucose infusion, and postnatal corticosteroid therapy for hypotension, adrenal insufficiency, and pulmonary immaturity. The use of long-acting insulin glargine has been described in the treatment of transient neonatal diabetes in the premature infant, but in these reports is a lack of regard to its use in the treatment of iatrogenic neonatal hyperglycemia. We present the case of an ELBW infant with significant hyperglycemia that was refractory to usual treatment but demonstrated a favorable response to long-acting subcutaneous insulin glargine. The pharmacokinetics on regular insulin and long-acting insulin are different. Regular insulin is broken down into biologically active monomers after subcutaneous injection, and long-acting insulin forms microprecipitates and is gradually released to the body at a neutral physiologic pH after subcutaneous injection. Pharmacokinetics of both regular insulin and long-acting insulin are not clear in ELBW infants. However, with further research on long-acting insulin, it can be used safely to achieve consistent euglycemia with once-daily administration in neonatal hyperglycemia.
引用
- Hwang MJ, Newman R, Philla K, et al. Use of Insulin Glargine in the Management of Neonatal Hyperglycemia in an ELBW Infant. Pediatrics. 2018. PMID: 29610159. doi:10.1542/peds.2016-1638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。